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The data show the frequencies by which the amino acid residues lysine,
histidine and cysteine of six proteins of the malaria parasite Plasmo-
dium falciparum are post-translationally modiﬁed by the lipoperox-
ydation endproduct 4-hydroxynonenal after challenging the parasitized
red blood cell with plakortin. Plakortin is an antimalarial endoperoxide
whose molecular anti-parasitic effect is described in Skorokhod et al.
(2015) [1]. Plakortin did not elicit hemoglobin leakage from host red
blood cells and did not oxidize reduced glutathione.
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
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E. Schwarzer et al. / Data in Brief 5 (2015) 893–899894ow data was
acquiredMALDI-TOF spectrometer (MALDI micro MX, Waters, Milford, MA, USA);
Luminometer Sirius (Berthold, Pforzheim, Germany)ata format Processed data
xperimental
factorsParasitized and non-parasitized red blood cells were kept in in vitro cell
culture up to 24 h. Chemical extraction for parameter assessment.xperimental
featuresHeme-dependent luminol-enhanced luminescence assay for hemoglobin.
Thiol-reaction with DTNB and OD measurement at 412 nm. Mass spectro-
metric analysis of peptides after trypsin-digestion of proteins.ata source
locationUniversity of Torino, Torino, Italyata accessibility Data are provided with this articleD
Value of the data
 The data show how endoperoxide-elicited oxidative stress might speciﬁcally target parasite
proteins of functional importance by binding the lipoperoxidation endproduct 4-HNE.
 Data on endoperoxide-elicited modiﬁcations of proteins of a unicellular parasite as molecular cause
for cell death may be of interest for similar studies with other microorganisms.
 Data for lethal modiﬁcations of speciﬁc microbial proteins with lipoperoxidation endproducts such
as 4-HNE may suggest a novel strategy for high throughput drug research, e.g. antimalarials.
 The data on host red blood cells (RBC) intactness may be useful to monitor host cell damage by
redox active substances.1. Data
1.1. Frequencies of lysine residues modiﬁed by 4-HNE
In Table 1 we list the number of lysine, histidine and cysteine residues (K, H and C, respectively)
that were found conjugated with 4-HNE and compare them with the total number of each of these
amino acids in the respective protein. The complete list of 4-HNE modiﬁed Plasmodium falciparum
proteins detected after plakortin treatment and speciﬁc sites of modiﬁcation are reported in [1].
There is no particular imbalance between the portion of 4-HNE-conjugated amino acids in the
proteins extracted from plakortin-treated parasites. We note that Plasmodium proteins contain ele-
vated % of asparagine and lysine residues [2], even more then in vertebrates, where K frequency is 2–3
times higher than that of H and C [3].
Evidently, availability of the amino acid residue for 4-HNE is a crucial factor for binding. C residues
engaged in disulﬁde bridges are no ligands for 4-HNE, while the basic amino acid K might be more
frequently exposed to the protein–solvent interface compared to H, and hence be more accessible to
4-HNE binding [4]. The data about unbalanced ratios were published for other proteins such as liver
fatty acid-binding protein [5], cytochrome c [6] and alpha-synuclein [7], where 4-HNE binding site
distribution between K, H, C was 4:1:1 [5]; 10:1:0 [6] and 2:1:0 [7] respectively.
1.2. Data for hemoglobin release from RBC under plakortin treatment
Culture of RBC infected (parasitized) with trophozoite-stage P. falciparum were treated with 0–
10 μM of plakortin and hemoglobin release was measured in culture supernatant (Fig. 1). The con-
centration is indicated in nmol/l. The concentration in the whole RBC suspension was 1 mM and
assessed after complete lysis of RBC in NaOH/Triton: this is the highest maximal achievable con-
centration of hemoglobin in the supernatant corresponding to 100% RBC lysis.
As shown in Fig. 1 the hemoglobin was not released from RBC even at 10 μM plakortin, the highest
applied concentration. Very low lysis was detectable in non-parasitized RBC (npRBC) and a still very
modest, although double as high value in trophozoite-parasitized mature forms of P. falciparum. This
Table 1
Lysine (K), histidine (H) and cysteine (C) frequency in the primary structure of P. falciparum proteins. Uniprot: Universal Protein Resource, www.uniprot.org/; NCBI GI: The National Center
for Biotechnology Information GenInfo Identiﬁer, www.ncbi.nlm.nih.gov/; PlasmoDB: the Plasmodium genome resource, http://PlasmoDB.org. Modiﬁcations at RING* stage and
TROPHOZOITE§ stage, only.
4-HNE-MODIFIED PROTEIN (NAME, ALIAS; IDs) 4-HNE BINDING SITES (distribution
between K, H, C)
K, H, C count in the protein sequence and the
total number of amino acids
1 *HSP70-1, HSP70_PLAFA K:17 K:54
Uniprot: Q8IB24_PLAF7 H:2 H:7
NCBI GI:124512406 C:2 C:9
PlasmoDB: PF3D7_0818900 Tot 680 AA
2 *V-type proton ATPase catalytic subunit A (EC 3.6.3.14), vacuolar
ATP synthase subunit a (vapA)
K:2 K:42
Uniprot: Q76NM6, VATA_PLAF7 H:0 H:6
NCBI GI:124512982 C:0 C:11
PlasmoDB: PF3D7_1311900 Tot 611 AA
3 *Enolase (EC 4.2.1.11) phosphopyruvate hydratase K:10 K:38
Uniprot: Q8IJN7, ENO_PLAF7 H:1 H:4
NCBI GI:124802328 C:1 C:6
PlasmoDB: PF3D7_1015900 Tot 446 AA
4 *Vacuolar protein sorting-associated protein 11, putative, former
RING ﬁnger protein PFE0100w
K:13 K:165
Uniprot: Q8I480-ZNRF2_PLAF7 H:0 H:31
NCBI GI:124505963 C:0 C:20
PlasmoDB: PF3D7_0502000 Tot 1272 AA
5 §DYHC1_PLAF7; Dynein heavy chain-like protein K:0 K:477
Uniprot: Q 8IBG1 H:3 H:79
NCBI GI:296004907 C:0 C:69
PlasmoDB:PF3D7_0729900 Tot 4985 AA
6 §Heat shock protein 70 (HSP70-2); BiP; GRP78 K:4 K:63
Uniprot: Q8I24_PLAF7 H:6 H:6
NCBI GI:124506906 C:2 C:2
PlasmoDB:PF3D7_0917900 Tot 652 AA
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Fig. 2. Quantiﬁcation of GSH in RBC treated or not with plakortin (1–100 μM, ﬁnal concentration). Columns present mean
GSH7SD values from 2 replicates performed with RBC from two donors.
Fig. 1. Hemoglobin release from incubated trophozoite-stage cultures and npRBC measured as heme concentration in culture
supernatant. Hemoglobin release was assessed 12 h after plakortin supplementation by heme-dependent luminol-enhanced
luminescence. A single point represents the mean of 3 replicates of one experiment. N¼3 independent experiments with
3 different blood donors.
E. Schwarzer et al. / Data in Brief 5 (2015) 893–899896elevated value in trophozoites depends on the parasite biology and is plakortin independent. Pla-
kortin has no effect on the barrier function of the host RBC membrane, irrespective whether para-
sitized or not.
1.3. Levels of reduced glutathione in plakortin-treated RBCs
Reduced glutathione (GSH) was quantiﬁed in RBC kept at 5% hematocrit in PBS supplemented with
20 mM glucose and plakortin for 24 h at 37 °C. As shown in Fig. 2 the GSH level in RBC remained
unchanged after plakortin supplementation in a wide concentration range from 1 to 100 μM.
E. Schwarzer et al. / Data in Brief 5 (2015) 893–899 8972. Experimental design, materials and methods
Unless otherwise stated all materials were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Plakortin, methyl 4,8-diethyl-6-methyl-3,6-peroxy-9-dodecenoate, was obtained from the organic
extract of the Caribbean sponge Plakortis simplex and puriﬁed by combination of column chromato-
graphy and HPLC as described [8]. The ﬁnal purity of the compound was 499%.
2.1. in vitro cultivation of Plasmodium falciparum and stage-speciﬁc enrichment of parasitized RBCs
P. falciparum (Palo Alto strain, Mycoplasma free) parasites were kept in permanent culture as
described [9–11]. RBC that were used for plakortin incubation experiments were from blood samples
taken on the same day of the experiment. Cultures were incubated in a humidiﬁed CO2 cell incubator
under a N2/CO2/O2 atmosphere of 90 vol%:5 vol%:5 vol%.
2.2. Plakortin treatment of parasitized RBC (pRBC) and npRBC
Pure plakortin was dissolved at 50 mM in ethanol (stock solution) and diluted to 10 mM (ﬁnal
concentration) with DMSO prior to use. The stock solution was kept at 20 °C until use. Synchronous
cultures were supplemented with a single dose of 10 mM plakortin at ring-stage (12–16 h post-
invasion) or at trophozoite-stage (26–30 h post-invasion) and kept under standard culture conditions
for 3 h until mass spectrometry analysis. Enriched parasite fractions and npRBCs were treated simi-
larly and kept under the same standard culture conditions.
2.3. Hemoglobin quantiﬁcation
The hemoglobin concentration in the culture supernatant was assayed by heme-dependent
luminol-enhanced luminescence. Luminescence was measured with a double-injector luminometer
(Sirius; Berthold, Pforzheim, Germany) as described [12–14]. All assays were performed in triplicate.
2.4. Preparation of protein extracts from pRBC
Washed and 1700 g sedimented npRBC or pRBC were hypo-osmotically lysed in a 10-fold excess
(v/v) of ice-cold lysis buffer (10 mM K2HPO4/KH2PO4 (pH 8.0)), supplemented with a protease inhi-
bitor cocktail containing: 1 mM EDTA, 250 μM phenyl-methyl-sulfonyl ﬂuoride (PMSF), 1 nM leu-
peptine, 3 μM pepstatine, the phosphatase inhibitors sodium orthovanadate and sodium ﬂuoride
each at 1 mM and 100 μM Trolox, during 5 min on ice. The ruptured membranes and organelles of
parasite origin were sedimented at 16,200 g for 3 min at 4 °C and the supernatant discarded. The
pellet was washed 10 times by re-suspension in fresh lysis buffer and subsequent sedimentation at
16,200 g for 1 min. pRBC preparations contained the host cell membrane as well as membranes and
organelle debris from the parasite. The proteins were extracted with SDS-containing Laemmli buffer
at 95 °C for 5 min. Solubilized proteins were kept at 20 °C prior to use and β-mercaptoethanol (5%
v/v) was added to protein samples before loading to the SDS-PAGE. The proteins were quantiﬁed
using the Bio-Rad Protein Assay (Bio-Rad, Hercules, CA, USA).
2.5. Identiﬁcation of 4-HNE modiﬁed proteins by mass spectrometric analysis and peptide mass
ﬁngerprinting
For the identiﬁcation of 4-HNE-conjugated proteins in plakortin-treated parasites, matrix assisted
laser desorption ionization-time of ﬂight (MALDI-TOF) mass spectrometric analysis was performed.
Proteins extracted from enriched ring and trophozoite stage pRBCs and npRBCs cultured with or
without 10 μM plakortin for 3 h were separated by SDS-PAGE. Gels were stained with colloidal
Coomassie, protein bands of interest excised from the gel and in-gel trypsin digested. MS analysis was
performed on a MALDI-TOF spectrometer MX; Waters, Milford, MA equipped with a delayed
extraction unit, according to the tuning procedures suggested by the manufacturer, operating in
E. Schwarzer et al. / Data in Brief 5 (2015) 893–899898reﬂectron mode [15,16]. Peak lists were generated by Protein Lynx Global Server (Waters, Milford,
MA). The 25 most intense masses were used for database searches against the SwissProt (Uniprot)
and NCBI databases using the free search program MASCOT (http://www.matrixscience.com). The
parameters used for the searches were: taxa P. falciparum, trypsin digestion, 1 missed cleavage,
methionine oxidation and 4-HNE as variable modiﬁcations with a maximum error allowed of
100 ppm. For P. falciparum, proteins taken on to consideration had a Mascot score higher than 37 for
SwissProt searches and higher than 67 for NCBI searches, as suggested by Mascot to be “signiﬁcant”.
2.6. GSH assay in RBC
Assay of GSH in RBC was performed according to [17]. GSH values were given as mM (μmol/ml
packed RBCs).
2.7. Statistical analysis
Non-parametric Mann–Whitney U Test was used to determine the signiﬁcance of differences
between the groups' means (PASW Statistics 18, SPSS IBM, Chicago, IL).Acknowledgments
The study was supported by the Italian Ministry for Research (MIUR PRIN2008, Leads ad attività
antimalarica di origine naturale. Isolamento, ottimizzazione e valutazione biologica), MIUR Grant
2010C2LKKJ-007 (E.S.), the University of Torino Intramural Funds (E.S.; O.A.S. PROG 101289 2012 and
2013, PROG 102326 2014) and EviMalaR (European Virtual Institute dedicated to Malaria Research)
Project no. 242095 (P.A.).References
[1] O.A. Skorokhod, D. Davalos-Schaﬂer, V. Gallo, E. Valente, D. Ulliers, A. Notarpietro, G. Mandili, F. Novelli, M. Persico,
O. Taglialatela-Scafati, P. Arese, E. Schwarzer, Oxidative stress-mediated antimalarial activity of plakortin, a natural
endoperoxide from the tropical sponge plakortis simplex, Free Rad. Biol. Med. 89 (2015) 624–637.
[2] E. Pizzi, C. Frontali, Low-complexity regions in plasmodium falciparum proteins, Genome Res. 11 (2001) 218–229.
[3] M. Kimura, Population Genetics Molecular Evolution, and the Neutral Theory, in: M. Kimura, N. Takahata, J.F. Crow (Eds.),
University of Chicago Press, Chicago, 1995, ISBN 10: 0226435628.
[4] E. Schwarzer, P. Arese, O.A. Skorokhod, Role of the lipoperoxidation product 4-hydroxynonenal in the pathogenesis of
severe malaria anemia and malaria immunodepression, Oxid. Med. Cell. Longev. 2015 (2015) 638416.
[5] R.L. Smathers, K.S. Fritz, J.J. Galligan, C.T. Shearn, P. Reigan, M.J. Marks, D.R. Petersen, Characterization of 4-HNE modiﬁed L-
FABP reveals alterations in structural and functional dynamics, PLoS One 7 (2012) e38459.
[6] X. Tang, L.M. Sayre, G.P. Tochtrop, A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modiﬁcation of cytochrome c,
J. Mass Spectrom. 46 (2011) 290–297.
[7] E.J. Bae, D.H. Ho, E. Park, J.W. Jung, K. Cho, J.H. Hong, H.J. Lee, K.P. Kim, S.J. Lee, Lipid peroxidation product 4-hydroxy-2-
nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein, Antioxid. Redox Signal. 18
(2013) 770–783.
[8] F. Caﬁeri, E. Fattorusso, O. Taglialatela-Scafati, A. Ianaro, Metabolites from the sponge Plakortis simplex. Determination of
absolute stereochemistry of plakortin. Isolation and stereostructure of three plakortin related compounds, Tetrahedron 55
(1999) 7045–7056.
[9] S. Uyoga, O.A. Skorokhod, M. Opiyo, E.N. Orori, T.N. Williams, P. Arese, et al., Transfer of 4-hydroxynonenal from parasitized
to non-parasitized erythrocytes in rosettes. Proposed role in severe malaria anemia, Br. J. Haematol. 157 (2012) 116–124.
[10] V. Gallo, O.A. Skorokhod, E. Schwarzer, P. Arese, Simultaneous determination of phagocytosis of plasmodium falciparum-
parasitized and non-parasitized red blood cells by ﬂow cytometry, Malar. J. 11 (2012) 428.
[11] A. Skorokhod, E. Schwarzer, G. Gremo, P. Arese, HNE produced by the malaria parasite plasmodium falciparum generates
HNE-protein adducts and decreases erythrocyte deformability, Redox Rep. 12 (2007) 73–75.
[12] E. Schwarzer, F. Turrini, P. Arese, A luminescence method for the quantitative determination of phagocytosis of ery-
throcytes, of malaria-parasitized erythrocytes and of malarial pigment, Br. J. Haematol. 88 (1994) 740–747.
[13] R. Aguilar, T. Marrocco, O.A. Skorokhod, A. Barbosa, A. Nhabomba, M.N. Manaca, C. Guinovart, L. Quintó, P. Arese, P.
L. Alonso, C. Dobano, E. Schwarzer, Blood oxidative stress markers and plasmodium falciparum malaria in non-immune
African children, Br. J. Haematol. 164 (2014) 438–450.
[14] J.W. Lin, R. Spaccapelo, E. Schwarzer, M. Sajid, T. Annoura, K. Deroost, et al., Replication of plasmodium in reticulocytes can
occur without hemozoin formation, resulting in chloroquine resistance, J. Exp. Med. 212 (2015) 893–903.
E. Schwarzer et al. / Data in Brief 5 (2015) 893–899 899[15] G. Mandili, A. Khadjavi, V. Gallo, V.G. Minero, L. Bessone, F. Carta, et al., Characterization of the protein ubiquitination
response induced by doxorubicin, FEBS J. 279 (2012) 2182–2191.
[16] O.A. Skorokhod, V. Barrera, R. Heller, F. Carta, F. Turrini, P. Arese, E. Schwarzer, Malarial pigment hemozoin impairs
chemotactic motility and transendothelial migration of monocytes via 4-hydroxynonenal, Free Radic. Biol. Med. 75 (2014)
210–221.
[17] E. Beutler, Red Cell Metabolism, A Manual of Biochemical Methods, 2nd ed., Grune and Stratton, New York, 1975.
